Jeffrey H Newcorn1, Iliyan Ivanov. Show Affiliations » 1. Mount Sinai School of Medicine, New York, USA.
Abstract
Entities: Disease
Mesh： See more » Adrenergic Uptake Inhibitors/administration & dosageAdrenergic Uptake Inhibitors/therapeutic useAntidepressive Agents/administration & dosageAntidepressive Agents/therapeutic useAtomoxetine HydrochlorideAttention Deficit and Disruptive Behavior Disorders/drug therapyAttention Deficit and Disruptive Behavior Disorders/physiopathologyBenzhydryl Compounds/therapeutic useCentral Nervous System Stimulants/therapeutic useConduct Disorder/drug therapyConduct Disorder/physiopathologyHumansModafinilNeurobiologyPediatricsPropylamines/therapeutic usePsychopharmacology/methodsSerotonin Uptake Inhibitors/therapeutic useUnited States
Substances： See more » Adrenergic Uptake InhibitorsAntidepressive AgentsBenzhydryl CompoundsCentral Nervous System StimulantsPropylaminesSerotonin Uptake InhibitorsAtomoxetine HydrochlorideModafinil
Year: 2007 PMID： 17910204 DOI： 10.3928/0090-4481-20070901-08
Source DB: PubMed Journal: Pediatr Ann ISSN： 0090-4481 Impact factor: 1.132